Drugs / hTERT vaccine
last change Dec 2017 re-read 2 minutes ago

hTERT vaccine

Vaccine

Developed for
plasma cell myeloma
Investigated by
University of Maryland, College Park · University of Pennsylvania

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00834665 Dec 2006 → Dec 2017 plasma cell myeloma University of Pennsylvania Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as hTERT vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00834665
Modality Vaccine “a multi-peptide vaccine consisting of 3 peptides against the catalytic subunit of telomerase” NCT00834665